Sath Shukla, EVP & CFO at Alaunos Therapeutics, holds 1.14M shares in Spero Therapeutics (Ticker: SPRO), holds 80.50K shares in Alaunos Therapeutics (Ticker: TCRT). Most recently, Sath Shukla Sold ― shares of Spero Therapeutics on Aug 29, 2024 for an estimated value of 3.72K.
What is the percentage of profitable transactions made by Sath Shukla?
The percentage of profitable transactions made by Sath Shukla is 75%.
What is the average return per transaction made by Sath Shukla?
The average return per transaction made by Sath Shukla is 3.20%.
What stocks does Sath Shukla hold?
Sath Shukla holds: TCRT, SPRO stocks.
What was Sath Shukla’s latest transaction?
Sath Shukla latest transaction was an Informative Sell of $3.72K.
What was Sath Shukla's most profitable transaction?
Sath Shukla’s most profitable transaction was an Informative Sell of SPRO stock on February 5, 2024. The return on the trade was 8.30%.
What is Sath Shukla's role in Alaunos Therapeutics?
Sath Shukla's role in Alaunos Therapeutics is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.